Fundamentals for Oxford Biomedica ( oxb )
Current Price: 3.10
Market Cap: 326.33m
Price / Net Assets: 1.38
Internal Rate of Return: 39.5%
PE10 Ratio: -35.36
Dividend Yield: 0%
Currency: £ GBP
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | Average |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (m) | £139.99m | £142.8m | £87.73m | £64.06m | £66.78m | £27.78m | £15.91m | £13.62m | £70m |
| Revenue Growth | -1.97% | 62.77% | 36.95% | -4.07% | 140.39% | 74.61% | 16.81% | - | 46% |
| Profit / Loss | £-45.16m | £19.01m | £-6.24m | £-16.07m | £7.54m | £-16.64m | £-13.02m | £-8.66m | £-10m |
| Profit Increase/Decrease | -337.56% | -404.65% | -61.17% | -313.13% | -145.31% | 27.80% | 50.35% | - | -169% |
| Profit / Sales Ratio | - | 13.31% | - | - | 11.29% | - | - | - | 3% |
| Earnings per Share | £-0.41 | £0.23 | £-0.08 | £-0.22 | £0.12 | £-0.01 | £-0.01 | £0.00 | £-0.05 |
| Total Debt | £223.99m | £49.89m | £71.18m | £47.30m | £77.66m | £44.32m | £40.96m | £10.76m | £70.76m |
| Net Assets | £236.19m | £187.34m | £112.75m | £75.63m | £34.74m | £12.62m | £10.89m | £23.04m | £86.65m |
| Debt / Asset Ratio | 48.67% | 21.03% | 38.70% | 38.48% | 69.09% | 77.84% | 79.00% | 31.83% | 31.83% |
| Dividend per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.00% |
| Dividend Cover | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0.00x |